Pharmaceutical Technology

DECEMBER 16, 2022

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% GnRH antagonists have an improved safety and efficacy profile compared to the marketed GnRH agonists, which have significant side effects that are unappealing to patients. of 7MM sales.

Marketing 59

Marketing Side effects Sales Safety 59

pharmaphorum

OCTOBER 27, 2022

The Swiss biotech is seeking a priority review for vamorolone, which was licensed from US biotech ReveraGen BioPharma in 2020 after Santhera its former DMD therapy candidate idebenone failed clinical testing and was abandoned.

FDA 98

FDA Side effects Biopharma Marketing 98

European Pharmaceutical Review

OCTOBER 7, 2022

Slow-release formulations were a popular choice for manufacturers, as these varieties reduce the traditional dosage frequency for patients, who only need to take these medications say, once a week. This is especially beneficial as a way of decreasing potential side effects.

Manufacturing 98

Manufacturing Marketing Side effects Transportation 98

Pharmaceutical Technology

AUGUST 17, 2022

The French vaccine producer Valneva had announced that it had a collaboration agreement with Pfizer to codevelop and commercialise VLA15 in April 2020. In a separate Phase II VLA15-221 study, which looked at adult and pediatric patients, the vaccine had stronger immunogenicity in children than in adults. of Valneva.

Medicine 119

Medicine Side effects Marketing Recruitment 119

pharmaphorum

JUNE 23, 2022

The deal comes a year after Intellia and partner Regeneron reported promising results from the first clinical trial of a drug used to edit the genomes of cells within the body, in patients with rare disease ATTR amyloidosis. billion agreement that started in 2020.

Side effects 97

Side effects Pharma Marketing Patients 97

pharmaphorum

AUGUST 5, 2022

Sanofi is making a €300 million investment in Chinese biotech Innovent as part of a collaboration to bring two new cancer therapies as quickly as possible to patients in the world’s second-largest pharma market. It is being tested in a wide range of solid tumours and lymphoma, alone and in combination with other drugs.

Side effects 104

Side effects Marketing Pharma Medicine 104

pharmaphorum

JULY 13, 2022

Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment. dosing of *first patient* with VERVE-101, an in vivo CRISPR base editing medicine. to patient volunteer $VERV [link].

Side effects 98

Side effects Medicine Patients Marketing 98

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. But it is not a simple answer. In fact, the number of new solutions just keeps growing every year.

Prescription 105

Prescription Medical Patients Side effects 105

Pharma Marketing Network

MAY 3, 2023

Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential side effects of different drugs. However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information.

Safety 52

Safety Food and Drug Administration Pharmaceutical Marketing 52

Pharma Marketing Network

SEPTEMBER 15, 2020

24, 2020 1:00 PM – 1:40 PM EDT | Innovative Ideas to Transform Your New Medication Launch: A Case Study and Panel Discussion. Thought leader experts will review the complexities and opportunities for life science companies to deliver new programs that achieve positive outcomes – for patients and their care teams.

Side effects 52

Side effects Medical Media Physicians 52

Referral MD

JULY 10, 2023

These intelligent digital assistants are revolutionizing how healthcare providers interact with patients, boosting engagement, streamlining support services, and enhancing patient experiences. Let’s explore the potential of AI chatbots in the sphere and find out how this technology can benefit healthcare providers and patients.

Patients 62

Patients Healthcare Healthcare Healthcare Provider 62

European Pharmaceutical Review

JANUARY 11, 2024

The current medications (opioid and non-opioid) often force the patients to make an unfortunate choice between efficacy and debilitating side effects, leading to a cycling through multiple different therapies and suboptimal treatment response. The present unmet needs within chronic pain are not met with opioid therapies.

Medicine 102

Medicine Pharmacology Management Side effects 102

Pharmaceutical Technology

JANUARY 27, 2023

However, Briumvi is unlikely to appeal to patients who are already receiving Genentech’s Ocrevus or Novartis’s Kesimpta. Briumvi is the third approved injectable MS treatment directed against CD20 antigen expressed on B cells, with the other therapies being Kesimpta (ofatumumab, approved in 2020) and Ocrevus (ocrelizumab, approved in 2017).

Marketing 52

Marketing Side effects Safety Patients 52

Pharmaceutical Technology

JUNE 12, 2023

A US Food and Drug Administration (FDA) Advisory Committee (AdCom) has unanimously voted in support of Eisai and Biogen’s Leqembi and its clinical benefit in patients with early Alzheimer’s disease , raising the drug’s full approval prospects. The trial reported a statistically significant reduction of clinical decline in the patients.

Food and Drug Administration 52

Food and Drug Administration Side effects Prospecting FDA 52

Impetus Digital

AUGUST 2, 2024

From the drug discovery phase to patient care, AI has the potential to enhance almost every stage of the product life cycle. In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal side effects. The pharmaceutical industry has numerous use cases for AI.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

PM360

OCTOBER 24, 2022

In December 2020, a startup out of southern California, Urovant Sciences, Inc., Extensive quantitative and qualitative research prioritized the most effective messaging with patients and with HCPs to develop an optimal story flow. This ensured a fast start to driving in-office discussions quickly at launch.

Side effects 40

Side effects Doctors FDA Patients 40

Pharmaceutical Technology

SEPTEMBER 26, 2022

The UK National Institute for Health and Care Excellence (NICE) has granted approval for Pfizer ’s palbociclib (Ibrance) in combination with anti-cancer therapy, fulvestrant, to treat advanced breast cancer patients. An inhibitor of cyclin-dependent kinase 4 and 6 (CDK4/6), palbociclib is administered once a day as a pill.

Side effects 52

Side effects Medicine Pharmaceutical Patients 52

pharmaphorum

JULY 19, 2022

China’s Simcere Pharmaceutical has been granted approval in its home market for Cosela, a drug designed to limit the side effects of cancer chemotherapy, partnered with US biotech G1 Therapeutics. It is also being tested in phase 3 trials involving patients with advanced colorectal cancer and triple-negative breast cancer (TNBC).

Side effects 59

Side effects Marketing Pharmaceutical Patients 59

pharmaphorum

OCTOBER 1, 2022

Shares in the company lost around 16% of their value after the top-line result of the REVERSE study in patients with compensated NASH-related cirrhosis were announced, as investors tried to work out what the failure will mean for the drug’s prospects. In REVERSE, 11.1%

Side effects 59

Side effects FDA Prospecting Pharma 59

European Pharmaceutical Review

JANUARY 25, 2024

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They detail the medication’s intended use, proper administration, potential side effects and precautions. percent as EU average with some Member States as high as 25 percent).

Healthcare 98

Healthcare Healthcare Safety Medicine 98

pharmaphorum

JUNE 28, 2022

Health2Sync provides patient management software for doctors and mobile app for patients that is designed to help them improve blood glucose control by encouraging adherence – for example by logging insulin doses – and provides advice on managing symptoms and potential side effects of therapy.

Side effects 52

Side effects Management Doctors Marketing 52

Pharmaceutical Technology

FEBRUARY 26, 2023

In March 2020, the FDA shared a safety alert on the use of faecal microbiota transplants (FMTs) due to Covid-19, which added questions identifying those infected with Covid-19 to donor screening protocols. Rebyota is a faecal microbiota-based treatment for patients with recurrent CDI that is administered through an enema. with placebo.

Safety 111

Safety FDA Medicine Side effects 111

Pharmaceutical Technology

APRIL 14, 2023

NASH is a form of nonalcoholic fatty liver disease (NAFLD), where patients develop excess fat in their liver. Alongside increased liver fat, NASH patients suffer from liver inflammation and damage that can eventually lead to fibrosis. The American agency previously rejected the company’s NDA for obeticholic acid in June 2020.

Side effects 52

Side effects Patients Leads Pharmaceutical 52

Pharmaceutical Technology

NOVEMBER 30, 2022

In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. Previously, the standard of care for obesity consisted of holistic changes to diet, exercise, and bariatric surgery for eligible patients.

Medical 105

Medical Manufacturing Insurance Side effects 105

European Pharmaceutical Review

SEPTEMBER 5, 2024

Cancer-associated fibroblasts, and their effects of the immune activity in the tumour, are considered one of the main reasons why around four out of five patients do not benefit from immunotherapies such as checkpoint inhibitors. For the 28 patients who received only pembrolizumab, the OS was 58 percent. 2020; 80(9):1846–60.

Medicine 59

Medicine Side effects Marketing Patients 59

Pharmaceutical Technology

NOVEMBER 30, 2022

In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. Previously, the standard of care for obesity consisted of holistic changes to diet, exercise, and bariatric surgery for eligible patients.

Medical 98

Medical Manufacturing Insurance Side effects 98

Pharmaceutical Representative Training

JANUARY 30, 2025

Imagine a patient who takes ibuprofen to treat a headache. A drugs solubility, how the liver metabolizes it, and patient-specific factors like genetics can influence the journey of a drug. These details are the reasons why knowledge of PK and PD is fundamental to making every drug both effective and safe for every patient.

Pharmacology 52

Pharmacology Side effects Distribution Sales 52

PM360

AUGUST 26, 2024

During the period from 2008 through 2020, the number of precision medicines in the US increased from 5 to 285. Over time, as professional judgement led to experimentation to achieve the desired patient reported outcome (PRO) the need to close the loop with targeted treatment and diagnostics became more acute. Bright Spots.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Contrarian Sales Techniques

FEBRUARY 10, 2023

They are designed to be safe and comfortable for patients, and typically have minimal side effects. Non-invasive healthcare products refer to medical devices or technologies that do not require puncturing the skin or entering the body in any way to diagnose, treat, or monitor a health condition.

Healthcare 52

Healthcare Healthcare Manufacturing Medical 52

Clarify Health

JULY 27, 2020

With the sudden physical distance between patients and healthcare facilities imposed by the lockdown, providers proved they could transition to virtual care instantly. At the pandemic’s first peak, non-urgent care services were paused across the US to make way for COVID-19 patients. Is lockdown creating a “hidden pandemic”?

Healthcare 52

Healthcare Healthcare Patients Safety 52

Pharmaceutical Technology

JANUARY 11, 2023

How patients receive treatment is being revolutionised by advancements in AI and machine learning, the internet of things (IoT) and extended reality, coupled with a growing comfort with digital devices including smartphones and telehealth, as a part of managing one’s care.

Healthcare 52

Healthcare Healthcare Medical Electronics 52

European Pharmaceutical Review

AUGUST 3, 2023

This study has been hailed as a breakthrough as the data show that Leqembi achieved a 27 percent reduction in the progression of Alzheimer’s, provided patients were treated early following the diagnosis of the disease. These treatments are thought to work best when administered to patients as early as possible post-diagnosis.

Food and Drug Administration 52

Food and Drug Administration Medicine FDA Marketing 52

World of DTC Marketing

JUNE 15, 2021

Doctors using telemedicine software are not sure of its value to patients and believe telehealth may pose risks. As one thought leader told me, “I need to see patients in person when they come in for a specific problem.” from 2020 to 2027. The hype around telehealth has followed a projected pattern.

Side effects 193

Side effects Insurance Doctors Pharma 193

World of DTC Marketing

AUGUST 1, 2022

“New weight loss drugs help patients lose significant weight,” but very few are telling the whole story. They can be expensive and have serious side effects. billion on hospice in 2020, according to a Medicare Payment Advisory Commission report to Congress. With the U.S. That’s up from $12.9

Healthcare 234

Healthcare Healthcare Insurance Prescription 234

PM360

MAY 25, 2023

And Mental Health America (MHA) found that between 2019 and 2020, 54.7% Currently, OM1 can harness real-world data from clinical notes obtained from more than 9,000 clinicians working in 2,500 clinics across all 50 states, and the company recently added data from more than 148,000 patients with schizophrenia and bipolar this past March.

Side effects 95

Side effects Medical Patients Networking 95

European Pharmaceutical Review

MARCH 9, 2023

A pilot study has demonstrated that a nasal version of the drug Foralumab, an anti-CD3 monoclonal antibody suppressed the inflammatory T cell response and decreased lung inflammation in patients with COVID-19. Foralumab’s immune modulating response In 2020, Moreira researched how Foralumab modulates the immune response to reduce inflammation.

Side effects 145

Side effects Patients Leads Medical 145

Pharmaceutical Technology

NOVEMBER 1, 2022

In a few weeks, the EU-funded research project Darwin EU will announce its first batch of data partners for the ambitious real-world data -driven Horizon 2020 project. In Estonia, every patient who visits a doctor immediately has their own personal e-Health record updated with new information, which can be referred to in future appointments.

Electronics 111

Electronics Prescription Healthcare Healthcare 111